SVB Wealth LLC Buys Shares of 430 Axon Enterprise, Inc. (NASDAQ:AXON)

SVB Wealth LLC acquired a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 430 shares of the biotechnology company’s stock, valued at approximately $256,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Geode Capital Management LLC grew its position in shares of Axon Enterprise by 2.0% during the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock worth $710,103,000 after buying an additional 35,320 shares in the last quarter. Westfield Capital Management Co. LP grew its position in shares of Axon Enterprise by 12.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after buying an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC grew its position in shares of Axon Enterprise by 13.9% during the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after buying an additional 83,265 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Axon Enterprise by 1.6% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock worth $224,281,000 after buying an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment acquired a new position in shares of Axon Enterprise during the third quarter worth about $200,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Axon Enterprise

In other news, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the completion of the sale, the director now owns 24,259 shares in the company, valued at $15,518,239.71. This represents a 3.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, President Joshua Isner sold 1,291 shares of the company’s stock in a transaction that occurred on Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total value of $829,377.13. Following the sale, the president now owns 181,892 shares of the company’s stock, valued at $116,852,877.56. This trade represents a 0.70 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,146 shares of company stock worth $3,262,847 over the last 90 days. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $534.96 on Thursday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The stock has a 50 day moving average of $605.52 and a two-hundred day moving average of $527.52. The stock has a market cap of $40.79 billion, a P/E ratio of 138.23, a P/E/G ratio of 5.17 and a beta of 1.12.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Barclays set a $726.00 price objective on Axon Enterprise and gave the stock an “overweight” rating in a research report on Thursday, February 27th. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target for the company. in a report on Thursday, February 20th. Robert W. Baird upped their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. The Goldman Sachs Group upped their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Finally, JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $587.38.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.